Last Updated: 03/14/2015 02:08:17
CLUB Stock Chart - 1 Month
CLUB Stock Chart - 3 Month
CLUB Stock Chart - 6 Month
CLUB Stock Chart - 1 Year
CLUB Stock Chart - 2 Year
A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...
Continue Reading
A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...
Continue Reading
With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...
Continue Reading
Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...
Continue ReadingA Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...
Continue Reading
Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...
Continue Reading
Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...
Continue Reading
Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...
Continue Reading
Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...
Continue Reading
Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...
Continue Reading
Fennec Pharmaceuticals Announces Participation in Key Conference Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a dynamic specialty pharmaceutical company recognized for its innovative approaches, has made a noteworthy announcement regarding its upcoming engagement in a significant investor conference. The company is set to participate in the 15th Annual...
Continue Reading
Transforming Active Trading with Level2 and Lightspeed In an exciting advancement for active traders, Level2 has partnered with Lightspeed Financial Services Group LLC to bring forth innovative, no-code systematic trading solutions. This collaboration unleashes a new level of trading capabilities, benefiting both novice and experienced traders alike. By integrating...
Continue Reading
The Rise of $MAD in the Meme Coin Landscape In today's dynamic meme coin market, where the landscape is constantly shifting, $MAD (Memes After Dark) is distinguishing itself as a noteworthy contender. It combines an engaging narrative with a supportive community, positioning itself among the leaders of this unique financial frontier. What makes $MAD particularly exciting...
Continue Reading
Exor N.V. Completes a Comprehensive Notes Offering Exor N.V. has recently marked a significant milestone with the successful closure of its €600 million notes offering. This move is a strategic part of Exor’s ongoing efforts to enhance its financial stability and expand its investment capacity. Details of the Notes Offering Priced on the 29th of October, the notes...
Continue Reading
Bundle x Joy Expands Dog Nutrition Offerings at PetSmart Bundle x Joy, a distinguished pet lifestyle brand founded by a Latina entrepreneur, is making waves in the pet industry by partnering with PetSmart, the largest specialty pet retailer in North America. This exciting collaboration makes their unique, allergy-friendly, and gut-healthy dog food available in over 500...
Continue Reading